Progresses towards safe and efficient gene therapy vectors
Metrics: PDF 5166 views | HTML 2339 views | ?
Sergiu Chira1, Carlo S. Jackson2, Iulian Oprea3, Ferhat Ozturk4, Michael S. Pepper2, Iulia Diaconu7, Cornelia Braicu1, Lajos-Zsolt Raduly1,10, George A. Calin8,9, Ioana Berindan-Neagoe1,5,6,8
1Research Center for Functional Genomics, Biomedicine and Translational Medicine, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj Napoca, Romania
2Department of Immunology and Institute for Cellular and Molecular Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
3Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
4Department of Molecular Biology and Genetics, Canik Başari University, Samsun, Turkey
5Department of Immunology, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj Napoca, Romania
6Department of Functional Genomics and Experimental Pathology, Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj Napoca, Romania
7BlueBird Bio, MA, USA
8Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
9Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
10Department of Physiopathology, Faculty of Veterinary Medicine, University of Agricultural Science and Veterinary Medicine, Cluj Napoca, Romania
George A. Calin, e-mail: email@example.com
Sergiu Chira, e-mail: firstname.lastname@example.org
Keywords: gene therapy, non-viral vectors, viral vectors, hybrid vectors, AAVP
Received: June 16, 2015 Accepted: August 22, 2015 Published: September 04, 2015
The emergence of genetic engineering at the beginning of the 1970′s opened the era of biomedical technologies, which aims to improve human health using genetic manipulation techniques in a clinical context. Gene therapy represents an innovating and appealing strategy for treatment of human diseases, which utilizes vehicles or vectors for delivering therapeutic genes into the patients' body. However, a few past unsuccessful events that negatively marked the beginning of gene therapy resulted in the need for further studies regarding the design and biology of gene therapy vectors, so that this innovating treatment approach can successfully move from bench to bedside. In this paper, we review the major gene delivery vectors and recent improvements made in their design meant to overcome the issues that commonly arise with the use of gene therapy vectors. At the end of the manuscript, we summarized the main advantages and disadvantages of common gene therapy vectors and we discuss possible future directions for potential therapeutic vectors.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.